Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bauer

Showing results (1191-1200 of 1,238) with videos related to

Pageof 124
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosaMarkus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Journal of Surgical Oncology|July 14, 2017
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinomaStefan Buettner, Boris Galjart, Jeroen L A van Vugt, et al.
Developmental Cell|May 4, 2022
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancerHarun Ozturk, Harun Cingoz, Turan Tufan, et al.
Journal of the American Academy of Dermatology|April 3, 2014
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classificationJo-David Fine, Leena Bruckner-Tuderman, Robin A J Eady, et al.
The British Journal of Dermatology|February 5, 2020
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragilityC Has, J W Bauer, C Bodemer, et al.
World Journal of Surgery|April 3, 2023
Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic CholangiocarcinomaYutaka Endo, Zorays Moazzam, Selamawit Woldesenbet, et al.
International Journal of Molecular Sciences|August 10, 2024
RiboScreen<sup>TM</sup> Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of ElastinBjoern Wimmer, Jan Schernthaner, Genevieve Edobor, et al.
JAMA Surgery|July 9, 2020
Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment ApproachesDiamantis I Tsilimigras, Kota Sahara, Lu Wu, et al.
World Journal of Surgery|June 18, 2025
Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver CancerAbdullah Altaf, Andrea Baldo, Mujtaba Khalil, et al.
Annals of Surgical Oncology|December 1, 2020
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?Diamantis I Tsilimigras, J Madison Hyer, Anghela Z Paredes, et al.
Pageof 124

Showing results (1191-1200 of 1,238) with videos related to

Sort By:
Pageof 124
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
Prime editing as a promising therapeutic strategy for junctional epidermolysis bullosaMarkus Hierl, Johannes Bischof, Bernadette Liemberger, et al.
Journal of Surgical Oncology|July 14, 2017
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinomaStefan Buettner, Boris Galjart, Jeroen L A van Vugt, et al.
Developmental Cell|May 4, 2022
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancerHarun Ozturk, Harun Cingoz, Turan Tufan, et al.
Journal of the American Academy of Dermatology|April 3, 2014
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classificationJo-David Fine, Leena Bruckner-Tuderman, Robin A J Eady, et al.
The British Journal of Dermatology|February 5, 2020
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragilityC Has, J W Bauer, C Bodemer, et al.
World Journal of Surgery|April 3, 2023
Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic CholangiocarcinomaYutaka Endo, Zorays Moazzam, Selamawit Woldesenbet, et al.
International Journal of Molecular Sciences|August 10, 2024
RiboScreen<sup>TM</sup> Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of ElastinBjoern Wimmer, Jan Schernthaner, Genevieve Edobor, et al.
JAMA Surgery|July 9, 2020
Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment ApproachesDiamantis I Tsilimigras, Kota Sahara, Lu Wu, et al.
World Journal of Surgery|June 18, 2025
Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver CancerAbdullah Altaf, Andrea Baldo, Mujtaba Khalil, et al.
Annals of Surgical Oncology|December 1, 2020
Tumor Burden Dictates Prognosis Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma: A Tool to Guide Post-Resection Adjuvant Chemotherapy?Diamantis I Tsilimigras, J Madison Hyer, Anghela Z Paredes, et al.
Pageof 124